Weill Cornell Medicine-Qatar, Education City, Qatar Foundation, Doha 24144, Qatar.
Viruses. 2020 Dec 30;13(1):51. doi: 10.3390/v13010051.
Bacteriophages represent an effective, natural, and safe strategy against bacterial infections. Multiple studies have assessed phage therapy's efficacy and safety as an alternative approach to combat the emergence of multi drug-resistant pathogens. This systematic review critically evaluates and summarizes published articles on phages as a treatment option for , , , and infection models. It also illustrates appropriate phage selection criteria, as well as recommendations for successful therapy. Published studies included in this review were identified through EMBASE, PubMed, and Web of Science databases and were published in the years between 2010 to 2020. Among 1082 identified articles, 29 studies were selected using specific inclusion and exclusion criteria and evaluated. Most studies (93.1%) showed high efficacy and safety for the tested phages, and a few studies also examined the effect of phage therapy combined with antibiotics (17.2%) and resistance development (27.6%). Further clinical studies, phage host identification, and regulatory processes are required to evaluate phage therapy's safety and efficacy and advance their clinical use.
噬菌体是一种有效、自然和安全的对抗细菌感染的策略。多项研究评估了噬菌体疗法作为一种替代方法来对抗多药耐药病原体的出现的疗效和安全性。本系统评价批判性地评估和总结了已发表的关于噬菌体作为治疗选择的文章,用于 、 、 和 感染模型。它还说明了适当的噬菌体选择标准以及成功治疗的建议。本综述中纳入的已发表研究通过 EMBASE、PubMed 和 Web of Science 数据库确定,并在 2010 年至 2020 年期间发表。在 1082 篇已确定的文章中,使用特定的纳入和排除标准选择了 29 项研究进行评估。大多数研究(93.1%)表明测试噬菌体具有高疗效和安全性,少数研究还检查了噬菌体治疗联合抗生素(17.2%)和耐药性发展(27.6%)的效果。需要进一步的临床研究、噬菌体宿主鉴定和监管程序来评估噬菌体治疗的安全性和疗效,并推进其临床应用。